| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |